| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.38 | 2e-07 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-07 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.33 | 1e-05 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-05 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |